VIRACTA THERAPEUTICS INC (VIRX)
US92765F1084 - Common Stock
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -47.99M | -51.06M | -49.20M | -114.76M | -21.61M | |||
| Depreciation Amortization | 482.00K | 492.00K | 210.00K | 180.00K | N/A | |||
| Change In Working Capital | 5.60M | 5.08M | 610.00K | 1.68M | -320.00K | |||
| Interest Paid | 3.34M | 3.07M | 450.00K | 340.00K | 340.00K | |||
| Other non cash items | 5.50M | 5.59M | 12.92M | 94.05M | 490.00K | |||
| OPERATING CASH FLOW | -36.40M | -39.89M | -35.46M | -18.85M | -21.44M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -138.00K | -50.00K | -250.00K | N/A | |||
| Other Investing Activity | 36.68M | 15.14M | -53.82M | 13.14M | 16.41M | |||
| INVESTING CASH FLOW | 36.54M | 15.00M | -53.87M | 12.89M | 16.41M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | 19.99M | -230.00K | -5.50M | |||
| Stock Issued/Repurchased | 498.00K | 438.00K | 2.56M | 62.66M | 12.68M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | -6.18M | 438.00K | 22.54M | 62.43M | 7.18M | |||
| CHANGE IN CASH | -6.04M | -24.46M | -66.79M | 56.47M | 2.15M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -36.40M | -39.89M | -35.46M | -18.85M | -21.44M | |||
| Capital Expenditure | N/A | -138.00K | -50.00K | -250.00K | N/A | |||
| FREE CASH FLOW | -36.54M | -40.03M | -35.51M | -19.10M | -21.44M | |||
All data in USD